Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Nachman

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
BMC Medicine|July 19, 2014
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of lifeVivek Naranbhai, Soyeon Kim, Helen Fletcher, et al.
BMC Research Notes|October 28, 2011
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) StudyClotilde Hainline, Reghana Taliep, Gill Sorour, et al.
The Lancet. HIV|December 12, 2018
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trialSharon Nachman, Carmelita Alvero, Hedy Teppler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1Paul Krogstad, Sophia Lee, George Johnson, et al.
Plos One|March 19, 2015
Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youthDonna J Curtis, Petronella Muresan, Sharon Nachman, et al.
Plos One|May 20, 2021
Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science studyYael Hirsch-Moverman, Andrea A Howard, Joanne E Mantell, et al.
Plos One|October 25, 2017
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African childrenLiusheng Huang, Vincent Carey, Jane C Lindsey, et al.
BMC Medicine|May 18, 2021
Evaluation of a serum-based antigen test for tuberculosis in HIV-exposed infants: a diagnostic accuracy studyLiyan Mao, Sylvia M LaCourse, Soyeon Kim, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and RegulationMoherndran Archary, Robert Bies, Osei Boateng, et al.
The Pediatric Infectious Disease Journal|February 13, 2002
Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infectionRam Yogev, Sophia Lee, Andrew Wiznia, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
BMC Medicine|July 19, 2014
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of lifeVivek Naranbhai, Soyeon Kim, Helen Fletcher, et al.
BMC Research Notes|October 28, 2011
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) StudyClotilde Hainline, Reghana Taliep, Gill Sorour, et al.
The Lancet. HIV|December 12, 2018
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trialSharon Nachman, Carmelita Alvero, Hedy Teppler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1Paul Krogstad, Sophia Lee, George Johnson, et al.
Plos One|March 19, 2015
Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youthDonna J Curtis, Petronella Muresan, Sharon Nachman, et al.
Plos One|May 20, 2021
Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science studyYael Hirsch-Moverman, Andrea A Howard, Joanne E Mantell, et al.
Plos One|October 25, 2017
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African childrenLiusheng Huang, Vincent Carey, Jane C Lindsey, et al.
BMC Medicine|May 18, 2021
Evaluation of a serum-based antigen test for tuberculosis in HIV-exposed infants: a diagnostic accuracy studyLiyan Mao, Sylvia M LaCourse, Soyeon Kim, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and RegulationMoherndran Archary, Robert Bies, Osei Boateng, et al.
The Pediatric Infectious Disease Journal|February 13, 2002
Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infectionRam Yogev, Sophia Lee, Andrew Wiznia, et al.
Pageof 11